Answer
Lecanemab is contraindicated with pre-treatment MRI findings of prior intracerebral haemorrhage, more than 4 microhaemorrhages, superficial siderosis or vasogenic oedema, which are suggestive of cerebral amyloid angiopathy.
Sources for this answer
- Leqembi 100 mg/mL concentrate for solution for infusionEisai Ltd · emc · SmPC §4.3 Contraindications · Version 6Document updated
Sources checked